Enriching stabilizing mutations through automated analysis of molecular dynamics simulations using BoostMut. [PDF]
Korbeld KT, Fürst MJLJ.
europepmc +1 more source
Refractory microsatellite-stable metastatic colorectal cancer: a comparison between botensilimab + balstilimab and current standard of care. [PDF]
Bengala E, Santini D, Picone V.
europepmc +1 more source
Analysis of fruquintinib in patients with metastatic colorectal cancer who were enrolled in Spain: results from the global FRESCO-2 study. [PDF]
Garcia-Carbonero R +13 more
europepmc +1 more source
The Early Movers Clinician's Guide: Co-Designing a Resource for the 24-Hour Movement Guidelines in Paediatric Occupational Therapy. [PDF]
Taylor LG +4 more
europepmc +1 more source
FRESCO-2 trial and fruquintinib: A clearer picture of the control arm. [PDF]
Ranganathan S +3 more
europepmc +1 more source
Comprehensive Characterization of the Microbiological and Quality Attributes of Traditional Sicilian Canestrato Fresco Cheese. [PDF]
Pisana C +8 more
europepmc +1 more source
Letter Re: Quality-adjusted survival in patients with metastatic colorectal cancer treated with fruquintinib plus best supportive care: results from FRESCO-2. [PDF]
Zhu W, Wei Z, Xie R.
europepmc +1 more source
Safety of fruquintinib mono- and combo therapy in metastatic colorectal cancer: real-world subgroup analysis from China. [PDF]
Wang Z +24 more
europepmc +1 more source
Small family cheesemaking in Mexico: Microbial quality and good manufacturing practices. [PDF]
Ibarra-Sánchez LA +3 more
europepmc +1 more source
Correction to: A Canadian real‑world, multi‑center, prospective, observational study assessing the treatment duration, the treatment sequence, and the overall survival for patients treated with endocrine therapy ± targeted therapy in HR + HER2‑negative advanced breast cancer. [PDF]
Doyle C +15 more
europepmc +1 more source

